Delivery Order SPE2DB20D3103-SPE2DB23FN4D2
Award Date 5/16/23
Potential Completion Date 6/7/23
Potential Value $74K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,718.02, is for the delivery of 1,400 mg - 23,400 11.7 ml vials of the drug Rituxan Hycela. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of March 17, 2025 and was awarded on February 24, 2025. This award is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,718.02 firm fixed price contract is for the delivery of RITUXAN HYCELA 1,400 MG-23,400 11.7ML medical supplies. The contract has a period of performance through July 24, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,436.04, is for the delivery of Rituxan Hycela, a medication used for the treatment of certain types of cancer and autoimmune disorders. The contract is a firm-fixed-price, non-set-aside delivery order with a performance period ending on May 19, 2025. AmerisourceBergen Drug Corp,...
- This federal contract award is for the delivery of Rituxan Hycela, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,334.26 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 21, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order valued at $7,836.46 to AmerisourceBergen Drug Corp for the supply of Rituxan Hycela 1,400 mg-23,400 11.7ml units. This is a firm fixed price delivery order with an ultimate completion date of December 16, 2025, issued on November 24, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $7,436.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rituxan Hycela 1,400 mg-23,400 11.7ml on October 22, 2025, with completion scheduled for November 13, 2025. This non-competitive delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of Rituxan Hycela (rituximab and hyaluronidase), a specialty pharmaceutical product used in oncology and immunology treatment regimens. The contract is valued at $3,718.02 with a firm fixed price structure and an ultimate completion date of October 8, 2025. This delivery order is non-set-aside and was competitively awarded,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Rituxan Hycela 1,600 mg-26,800 13.4 mL, a biologic immunosuppressant medication used to treat rheumatoid arthritis and certain cancers. This non-set-aside, firm fixed-price delivery order has a ceiling value of $4,560.99 and an ultimate completion date of December 1, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RITUXAN HYCELA, a medication used to treat certain types of cancer and autoimmune disorders, with a ceiling value of $22,531.18. The contract is a firm fixed price, non-set-aside award with an ultimate completion date of August 5, 2025. Amerisourcebergen Drug Corp holds a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $34,870.50 for Rituxan Hycela (1,600 mg-26,800 13.4 mL) on November 20, 2025, with an ultimate completion date of December 12, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. The award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...